<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title-group>
        <journal-title>Molecular Vision</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21423868</article-id>
      <article-id pub-id-type="pmc">3060157</article-id>
      <article-id pub-id-type="publisher-id">80</article-id>
      <article-id pub-id-type="publisher-id">2011MOLVIS0050</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Genetic and genomic analysis of classic aniridia in Saudi Arabia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Arif O.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aldahmesh</surname>
            <given-names>Mohammed A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Alkuraya</surname>
            <given-names>Fowzan S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>Division of Pediatric Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia</aff>
        <aff id="aff2"><label>2</label>Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia</aff>
        <aff id="aff3"><label>3</label>Department of Pediatrics, King Khalid University Hospital and College of Medicine, King Saud University, Riyadh, Saudi Arabia</aff>
        <aff id="aff4"><label>4</label>Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia</aff>
      </contrib-group>
      <author-notes>
        <fn>
          <p>The first two authors contributed equally to the work</p>
        </fn>
        <corresp id="cor1">Correspondence to: Fowzan S. Alkuraya, M.D., Developmental Genetics Unit, Department of Genetics, King Faisal Specialist Hospital and Research Center, MBC 03, PO Box 3354, Riyadh 11211 Saudi Arabia; Phone: +966 1 442 7875; FAX: +966 1 442 4585; email: <email xlink:href="falkuraya@kfshrc.edu.sa">falkuraya@kfshrc.edu.sa</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <fpage>708</fpage>
      <lpage>714</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 Molecular Vision.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To determine the genetic and genomic alterations underlying classic aniridia in Saudi Arabia, a region with social preference for consanguineous marriage.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Prospective study of consecutive patients referred to a pediatric ophthalmologist in Saudi Arabia (2005&#x2013;2009). All patients had paired box gene 6 (<italic>PAX6</italic>) analysis (sequencing and multiplex ligation-dependent probe amplification analysis if sequencing was normal). If <italic>PAX6</italic> analysis was negative, the following were performed: candidate gene sequencing (forkhead box C1 [<italic>FOXC1</italic>], paired-like homeodomain transcription factor 2 [<italic>PITX2</italic>], cytochrome P450, family 1, subfamily B [<italic>CYP1B1</italic>], paired-like homeodomain transcription factor 3 [<italic>PITX3</italic>], and v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog [<italic>MAF</italic>]) and molecular karyotyping by array competitive genomic hybridization (250K single nucleotide polymorphism (SNP) arrays).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>All 12 probands (4 months &#x2013; 25 years of age; four boys and eight girls) had lens opacity and foveal hypoplasia in addition to no  grossly visible iris. Four cases were familial. All cases were products of consanguineous unions except for three, one of which was endogamous. Heterozygous <italic>PAX6</italic> mutations (including two novel mutations) were detectable in all but two cases, both of which were sporadic. In one of these two cases, the phenotype segregated with homozygosity for a previously-reported pathogenic missense <italic>FOXC1</italic> variant (p.P297S) when homozygosity for chromosome 11q24.2 deletion (chr11:125,001,547&#x2013;125,215,177 [rs114259885; rs112291840]) was also present. In the other, no genetic or genomic abnormalities were found.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The classic aniridia phenotype in Saudi Arabia is typically caused by heterozygous <italic>PAX6</italic> mutations, even in the setting of enhanced homozygosity from recent shared parental ancestry. For <italic>PAX6</italic>-negative cases, interaction between missense variation in an anterior segment developmental gene and copy number variation elsewhere in the genome may be a potential mechanism for the phenotype.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>corr-author</meta-name>
          <meta-value>Alkuraya</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Classic aniridia (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/106210">106210</ext-link>) is a panocular disorder which, in addition to lack of grossly visible iris, is characterized by keratopathy, lens opacity, juvenile-onset glaucoma, foveal hypoplasia, and optic nerve hypoplasia [<xref ref-type="bibr" rid="r1">1</xref>]. This classic phenotype is caused by heterozygous mutation in the ocular developmental gene paired box gene 6 (<italic>PAX6</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/607108">*607108</ext-link>; 11p13), typically through haploinsufficiency [<xref ref-type="bibr" rid="r2">2</xref>]. For cases in which the contiguous gene Wilms tumor 1 (<italic>WT1</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/194070">194070</ext-link>; 11p13) is also disrupted, affected children are typically syndromic and at risk for juvenile Wilms tumor of the kidney (WAGR syndrome, OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/194072">194072</ext-link>) [<xref ref-type="bibr" rid="r3">3</xref>]. Previous studies have shown that dominant <italic>PAX6</italic> mutations are the only known cause of classic aniridia. However, even with comprehensive analysis of <italic>PAX6</italic> including copy number analysis, up to 10% of classic anirida cases have no identifiable mutation [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r4">4</xref>].</p>
      <p>Congenital iris abnormality in general can also be due to heterozygous <italic>PAX6</italic> mutation but is both phenotypically and genotypically more heterogenous. Heterozygous mutation in the ocular developmental gene forkhead box C1 (<italic>FOXC1</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/601090">*601090</ext-link>; 6p25) or paired-like homeodomain transcription factor 2 (<italic>PITX2</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/601542">*601542</ext-link>; 4q25-q26) causes the Axenfeld-Rieger spectrum (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/602482">602482</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/180500">180500</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/137600">137600</ext-link>), an anterior segment dysgenesis which can include mild iris stromal hypoplasia, corectopia, polycoria, iris pigment border hyperplasia (&#x201C;ectropion uvea&#x201D;), and/or virtually complete lack of iris [<xref ref-type="bibr" rid="r5">5</xref>]. <italic>FOXC1</italic> duplication can cause the phenotype as well [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. Affected children have a propensity for congenital or juvenile glaucoma, can have neural crest-related non-ocular findings (e.g., maxillary hypoplasia, dental anomalies), and can show significant intrafamilial phenotypic variation for the same mutation [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r9">9</xref>]. Congenital iris abnormality can also occur in the setting of congenital glaucoma from homozygous or compound heterozygous mutations in cytochrome P450, family 1, subfamily B (<italic>CYP1B1</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/601771">*601771</ext-link>; 2p22-p21) [<xref ref-type="bibr" rid="r10">10</xref>], in the setting of anterior segment mesenchymal dysgenesis due to heterozygous mutation in paired-like homeodomain transcription factor 3 (<italic>PITX3</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/602669">+602669</ext-link>; 10q25) [<xref ref-type="bibr" rid="r11">11</xref>], and in the setting of anterior segment dysgenesis due to heterozygous mutation in v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog (<italic>MAF</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/177075">*177075</ext-link>; 16q22-q23) [<xref ref-type="bibr" rid="r12">12</xref>]. The variation in iris phenotype for a given mutation that has been observed in <italic>FOXC1</italic>-related disease as well as in other genetic causes of congenital iris abnormality is likely related to the influence of yet unidentified modifiers.</p>
      <p>Although a small percentage of aniridia cases have no detectable <italic>PAX6</italic> mutation, to the best of our knowledge no other genotype has been associated with the classic aniridia phenotype. We propose two potential causes for <italic>PAX6</italic>-negative classic anirida: 1) genomic alteration that affect cis or trans regulatory elements of <italic>PAX6</italic>, or 2) point mutations or deletions in other genes known to be involved in the pathogenesis of congenital iris abnormalities. Genome-wide copy number analysis of classic aniridia cases with negative <italic>PAX6</italic> sequencing can investigate the first possibility. In addition to interrogation for genomic alteration in a genome-wide fashion, this would also further characterize <italic>PAX6</italic> deletions. Regarding the second possibility, i.e., mutations in other known genes, gross deletions would also be uncovered by genome-wide copy number analysis while sequencing variants can be investigated by direct sequencing of a panel of genes known to cause congenital iris abnormalities when mutated. Moreover, if recessive mutation in other known genes can cause classic aniridia, this would most likely be uncovered by the study of affected consanguineous families, for whom a recessive cause is more likely to be found if a recessive cause for the phenotype exists [<xref ref-type="bibr" rid="r13">13</xref>]. In the current study, we analyze the underlying genotype of classic aniridia in mostly consanguineous patients by <italic>PAX6</italic> analysis and, for <italic>PAX6</italic>-negative cases, by candidate gene sequencing and array genomic copy number variation analysis.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Institutional review board approval was obtained for this study (KFSHRC IRB #2070023</p>
      <p>KKESH IRB #?????). Consecutive patients with classic aniridia referred to the pediatric ophthalmology service of one of the authors (A.O.K.) from 2005 to 2009 were prospectively enrolled in the study. Classic anirida was defined as no grossly visible iris in addition to keratopathy, lens opacity, and/or foveal hypoplasia [<xref ref-type="bibr" rid="r1">1</xref>]. Patients underwent complete ophthalmic examination and venous blood sampling for analysis. The strategy for genetic and genomic analysis was as follows: If direct sequencing did not reveal <italic>PAX6</italic> mutation, multiplex ligation-dependent probe amplification (MLPA) was performed to assess for <italic>PAX6</italic> deletions. If this was normal, the candidate genes <italic>FOXC1, PITX2</italic>, <italic>CYP1B1, PITX3</italic>, and <italic>MAF</italic> were sequenced. In addition, genomic molecular karyotyping was performed via array-based comparative genomic hybridization (array CGH) in all cases that lacked an identifiable <italic>PAX6</italic> mutation. When available and appropriate, relatives underwent ophthalmic examination and venous blood sampling for confirmatory genetic analysis.</p>
      <sec>
        <title>DNA extraction</title>
        <p>Genomic DNA was extracted from whole blood anti-coagulated with EDTA using the Purgene Gentra DNA Extraction Kit (Cat. # D-5000; Gentra Systems, Minneapolis, MN) according to the manufacturer&#x2019;s instructions. The DNA was quantified spectrophotometrically and stored in aliquots at &#x2212;20&#xA0;&#xB0;C until required.</p>
      </sec>
      <sec>
        <title>PCR amplification and DNA sequencing</title>
        <p>PCR amplification was performed on a thermocycler (DNA Engine Tetrad, MJResearch, Inc., Hercules, CA) in a total volume of 25&#xA0;&#xB5;l, containing 10 ng DNA, 50&#xA0;mM KCl, 10&#xA0;mM Tris-HCl (pH 9.0), 1.5&#xA0;mM MgCl<sub>2</sub>, 0.1% Triton X-100, 0.25m M of each dNTP, 0.8&#xA0;&#xB5;M of each primer and 0.5 Units of Taq polymerase (D-40724; QIAGEN, Hilden, Germany). For PCR, an initial denaturation step at 95&#xA0;&#xB0;C for 10 min was followed by 40 cycles of denaturation at 95&#xA0;&#xB0;C for 30 s, annealing at 59&#xA0;&#xB0;C for 30 s and extension at 72&#xA0;&#xB0;C for 30 s followed by a final extension step of 72&#xA0;&#xB0;C for 10 min. Genomic DNA of each patient was screened for coding regions and boundary site variants by sequencing reactions using BigDye&#xAE; Terminator v 3.0 (Applied Biosystems, Inc., Foster City, CA). Following the manufacturer&#x2019;s instructions, sequencing reactions were desalted and unincorporated nucleotides removed using ethanol precipitation and re-suspended in a deionized distilled water for injection on a Applied Biosystems 3730xl DNA Analyzer (Applied Biosystems, Inc.). Sequence analysis was performed using the SeqManII module of the Lasergene (DNA Star Inc., Madison, WI) software package and was compared to the relevant reference sequence.</p>
      </sec>
      <sec>
        <title>MLPA analysis</title>
        <p>MLPA analysis of <italic>PAX6</italic> was performed using the commercial Kit P219 PAX6 (MCR Holland, Amsterdam, The Netherlands). The manufacturer&#x2019;s instructions were followed and data was analyzed using Coffalyser software (MCR Holland).</p>
      </sec>
      <sec>
        <title>Molecular karyotyping</title>
        <p>Affymetrix Genechip Human Mapping 250K SNP arrays (Affymetrix, Santa Clara, CA) were used. All procedures were performed according to Affymetrix standard protocols. The SNP call rate and sample mismatch report was determined with GTYPE software (Affymetrix). Two algorithms, the Affymetrix&#xAE; Genotyping Console&#x2122; and Copy Number Analyzer for GeneChip&#xAE; arrays (CNAG) Version 3.021 software were used to infer copy number variation among affected individuals based on the hybridization intensity signal of the probes.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Twelve probands (four familial, eight sporadic) were included in the study &#x2013; four boys and eight girls who ranged from 4 months to 25 years of age. Two of the familial cases were previously-reported [<xref ref-type="bibr" rid="r14">14</xref>]. All patients were products of consanguineous unions except for three cases, one of which was endogamous. None had associated non-ocular congenital malformation or complicated birth history and all had had comprehensive physical examination by a pediatrician. All probands had lens opacity, foveal hypoplasia, and gross lack of iris; in addition, all probands had keratopathy except for two sporadic cases (patients 7 and 12 in <xref ref-type="table" rid="t1">Table 1</xref>). All four familial cases and six of the eight sporadic cases had <italic>PAX6</italic> mutation, including two novel <italic>PAX6</italic> mutations (<xref ref-type="table" rid="t1">Table 1</xref>, <xref ref-type="fig" rid="f1">Figure 1</xref>, and <xref ref-type="fig" rid="f2">Figure 2</xref>). The two sporadic cases without detectable <italic>PAX6</italic> mutation (patients 7 and 9 in <xref ref-type="table" rid="t1">Table 1</xref>), both from consanguineous families, are discussed further below.</p>
      <table-wrap id="t1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Summary of the results of molecular analysis of patients with classic aniridia.</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="24" span="1"/>
          <col width="57" span="1"/>
          <col width="32" span="1"/>
          <col width="28" span="1"/>
          <col width="16" span="1"/>
          <col width="137" span="1"/>
          <col width="108" span="1"/>
          <col width="135" span="1"/>
          <col width="113" span="1"/>
          <thead>
            <tr>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>ID</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Inbred?</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Age</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Sex</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>#</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>PAX6 mutation</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Gene analysis</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Copy number variation</bold>
              </th>
              <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                <bold>Comment</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">6<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">9<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Arg240X (c.1195C&gt;T)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Family from reference [<xref ref-type="bibr" rid="r14">14</xref>]<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">2<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">**p.E185EfsX14 (c.555_556delGA)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">3<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">9<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">3<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Pro39ArgfsX14 (c.112del1)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">4<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">8<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Asn273IlefsX91 (c.delA1294)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Family from reference [<xref ref-type="bibr" rid="r14">14</xref>]<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">5<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">25<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">M<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Arg240X (c.718C&gt;T)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">6<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">9<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">M<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">** p.Gln350X (c.1048C&gt;T)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">developed juvenile glaucoma<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">7<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">8<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">none<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">no mutation found<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">none found<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">no keratopathy<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">8<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">7<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">M<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Ala37ProfsX16 (c.109del1)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">accommodative esotropia<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">9<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">7<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">none<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">homozygous p.Pro297Ser FOXC1 (c.889C&gt;Tr)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">chr11q24.2:125,001,547-125,215,177 (rs114259885;rs112291840)<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">10<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">3<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">M<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">p.Ser167X (c.500C&gt;A)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">optic nerve hypoplasia<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">11<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Consang<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1"><italic>PAX6</italic> gene deletion (see copy number variation column)<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A<hr/></td>
              <td valign="top" align="center" rowspan="1" colspan="1">chr11:30,877,006-32,440,841 (1,563,836 bp)<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td valign="top" align="center" scope="row" rowspan="1" colspan="1">12</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Endogom</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4/12</td>
              <td valign="top" align="center" rowspan="1" colspan="1">F</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1"><italic>PAX6</italic> and <italic>WT</italic>1 gene deletion (see copy number variation column)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A</td>
              <td valign="top" align="center" rowspan="1" colspan="1">chr11:27,206,264-42,280,976 (15,074,713 bp)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Non-consanguineous but endogamous; no keratopathy</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>#denotes number of affected individuals), N/A: not applicable; **denotes novel mutation. Consang: consanguineous; Endogom: endogamous.</p>
        </table-wrap-foot>
      </table-wrap>
      <fig id="f1" fig-type="figure" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Patient 2, without pharmacologic mydriasis. <bold>A</bold>: Retroillumination shows lack of iris and the lenticular changes (left eye shown). <bold>B</bold>: Diffuse illumination reveals surface keratopathy (left eye shown). <bold>C</bold>: There was no defined fovea by indirect ophthalmoscopy (left eye shown). <bold>D</bold>: sequencing revealed a novel <italic>PAX6</italic> mutation (p.E185EfsX14).</p>
        </caption>
        <graphic xlink:href="mv-v17-708-f1"/>
      </fig>
      <fig id="f2" fig-type="figure" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Patient 6, without pharmacologic mydriasis. <bold>A</bold>: Slit illumination revealed surface limbal keratopathy (right eye shown). <bold>B</bold>: Slit illumination shows lack of iris and a posterior lenticular opacity (right eye shown). <bold>C</bold>: The fovea is not well defined (right eye shown). <bold>D</bold>: sequencing revealed a novel <italic>PAX6</italic> mutation (p.Q350X).</p>
        </caption>
        <graphic xlink:href="mv-v17-708-f2"/>
      </fig>
      <p>Patient 7 (<xref ref-type="fig" rid="f3">Figure 3</xref>) had classic aniridia in that in addition to lack of iris she had lens opacity and foveal hypoplasia. She had normal genetic and genomic analysis; no underlying cause was found for the ocular phenotype.</p>
      <fig id="f3" fig-type="figure" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Patient 7, without pharmacologic mydriasis. <bold>A</bold>, <bold>B</bold>: In addition to lack of iris, this patient without detectable <italic>PAX6</italic> mutation had lenticular opacity and foveal hypoplasia (not shown). Further genetic and genomic analyses were unremarkable. The right eye is shown.</p>
        </caption>
        <graphic xlink:href="mv-v17-708-f3"/>
      </fig>
      <p>Patient 9 (<xref ref-type="fig" rid="f4">Figure 4</xref>) had classic aniridia in that in addition to lack of iris she had keratopathy, lens opacity, and foveal hypoplasia. She was homozygous for a missense variant in <italic>FOXC1</italic> (p.P297S) that was previously been reported as pathogenic and as a cause for dominant anterior segment dysgenesis in two unrelated individuals [<xref ref-type="bibr" rid="r15">15</xref>]. However, her father was heterozygous for the variant while her mother was homozygous and neither parent had significant ophthalmic findings despite careful clinical ophthalmic examination with attention to the anterior segment and fovea. Molecular karyotyping revealed homozygosity (nullizygosity) for a chromosome 11q24.2 deletion (chr11:125,001,547&#x2013;125,215,177 [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs114259885">rs114259885</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs112291840">rs112291840</ext-link>]) present in the child and heterozygosity (hemizygosity) for the deletion in both parents. Thus the child's phenotype segregated with homozygosity for the <italic>FOXC1</italic> missense variant in conjunction with homozygosity for the deletion (<xref ref-type="fig" rid="f4">Figure 4</xref>). The region of this deletion contains five genes (CHK1 checkpoint homolog [<italic>CHEK1</italic>], acrosomal vesicle protein 1 [<italic>ACRV1</italic>], prostate and testis expressed 4 [<italic>PATE4</italic>], prostate and testis expressed 2 [<italic>C11ORF38</italic>], and <italic>FLJ41047</italic>), none of which has known ocular function. Neither the FOXC1 variant nor the deletion was found in 100 ethnically-matched controls.</p>
      <fig id="f4" fig-type="figure" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Patient 9, without pharmacologic mydriasis. <bold>A</bold>, <bold>B</bold>: In addition to lack of iris, this patient without detectable <italic>PAX6</italic> mutation had anterior lens opacity, limbal keratopathy (not shown), and foveal hypoplasia. <bold>C</bold>: Further genetic and genomic analyses revealed homozygosity for both a previously-described heterozygous <italic>FOXC1</italic> mutation (p.P279S) and a for chromosome 11q24.2 deletion (<bold>D</bold>) while neither unaffected parent was homozygous for both.</p>
        </caption>
        <graphic xlink:href="mv-v17-708-f4"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>In this series of classic aniridia in mostly consanguineous families from Saudi Arabia, the heterozygous <italic>PAX6</italic> mutation was detected in 4/4 familial cases and 6/8 sporadic cases. One P<italic>AX6</italic>-negative case harbored homozygosity for both a previously-reported pathogenic missense <italic>FOXC1</italic> variant and for a deletion on chromosome 11q24.2; the unaffected parents were heterozygous or homozygous for the <italic>FOXC1</italic> variant and both were heterozygous for the deletion. The other P<italic>AX6</italic>-negative case remained idiopathic despite candidate gene sequencing and whole genome copy number analysis.</p>
      <p>Studies of consanguineous families are more likely to uncover a recessive cause for a given phenotype if a recessive cause exists because of parental shared recent ancestry. Every individual is a heterozygous carrier for mutated alleles that would potentially cause recessive disease in the homozygous (or compound heterozygous) state. Consanguineous marriage increases the expression of rare recessive disease because unless carriers are related, they are unlikely to marry a partner who carries the same disorder [<xref ref-type="bibr" rid="r16">16</xref>]. In the current study of classic aniridia of mostly inbred families, 3/3 familial cases from consanguineous families and 6/8 sporadic cases from consanguineous or endogamous families harbored heterozgyous <italic>PAX6</italic> mutation. Thus even in the setting of enhanced homozygosity from recent shared parental ancestry, heterozgyous <italic>PAX6</italic> mutation typically underlies the phenotype of classic aniridia.</p>
      <p>Two patients, both from consanguineous families, had no detectable <italic>PAX6</italic> mutation. Although no genetic or genomic cause for classic aniridia was found in one (Patient 7, <xref ref-type="fig" rid="f3">Figure 3</xref>), in the other (Patient 9, <xref ref-type="fig" rid="f4">Figure 4</xref>) there was a homozygous <italic>FOXC1</italic> missense variant previously reported as responsible for anterior segment dysgenesis in the heterozygous state [<xref ref-type="bibr" rid="r15">15</xref>]. However, both unaffected and otherwise normal parents of the patient harbored this variant &#x2013; in the heterozygous state in the father and in the homozygous state in the mother &#x2013; and both unaffected parents had no significant ophthalmic findings. Additional analysis by array CGH revealed a homozygous deletion in the child on chromosome 11q24.2 that was present in the heterozygous state in both parents. One can speculate that either the homozygous 11q24.2 deletion alone or in concert with the homozygous <italic>FOXC1</italic> missense variant was associated with the classic aniridia phenotype. The latter seems more plausible as the genes affected by the deletion do not have known ocular function while p.P297S FOXC1 has been previously described as pathogenic [<xref ref-type="bibr" rid="r15">15</xref>]. Functional work suggests that p.P297S FOXC1 alters interaction with other yet unidentified factors involved in FOXC1 transactivation and degradation, thus extending the half-life of the protein and causing an increased dosage effect akin to the mechanism of <italic>FOXC1</italic> duplication [<xref ref-type="bibr" rid="r15">15</xref>]. Consistent with this, cases associated with p.P297S FOXC1 as well as those associated with <italic>FOXC1</italic> duplication have been reported with phenotypes of iridogoniodysgeneis that can resemble the iris appearance of patients with classic anirida [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. While the genes contained within this 11q24.2 deletion are not known to be involved in eye development, such a role has not been excluded. In addition, we cannot exclude the possibility that non-coding regulatory elements for <italic>PAX6</italic> may exist within this region. Either of these two hypothesized causal links could be either sufficient or dependent on the <italic>FOXC1</italic> mutation. Patient 9 also had developmental delay, which may or may not have been related to the deletion alone or in combination with p.P297S FOXC1.</p>
      <p>For a particular mutation in a given gene, differences in a given individual's background genotype and environmental exposure cause intrafamilial phenotypic variability. Intrafamilial phenotypic variability has been well documented for <italic>FOXC1</italic>-related disease [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r9">9</xref>]. Background genomic copy number variation &#x2013; both deletion and repeats &#x2013; can increase susceptibility to ocular disease and contribute to phenotypic variability [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. In patient 9 from this study (<xref ref-type="fig" rid="f4">Figure 4</xref>), the homozygous deletion may have been responsible for the expression of a p.P279S FOXC1-related anterior segment phenotype, i.e., the homozygous deletion is a genomic explanation for the intrafamilial phenotypic variability and the observed classic aniridia in patient 9. Although there have been reports of lack of visible iris in patients with heterozygous <italic>FOXC1</italic> [<xref ref-type="bibr" rid="r20">20</xref>] as well as heterozygous <italic>PITX2</italic> [<xref ref-type="bibr" rid="r21">21</xref>] mutations, these previously-reported patients would not be considered classic aniridia as they did not have documented keratopathy, lens opacity, or foveal hypoplasia. In addition, the previously-reported patient [<xref ref-type="bibr" rid="r20">20</xref>] with lack of iris and heterozgyous <italic>FOXC1</italic> mutation also had obvious newborn glaucoma, which is not part of classic aniridia [<xref ref-type="bibr" rid="r10">10</xref>]. There is a previous report of gross lack of iris and concurrent keratopathy associated with heterozygous <italic>FOXC1</italic> mutation; this was in a baby boy who also had severe newborn glaucoma [<xref ref-type="bibr" rid="r22">22</xref>]. Again, his phenotype would not be considered classic aniridia because of newborn glaucoma [<xref ref-type="bibr" rid="r10">10</xref>].</p>
      <p>Our finding of a homozygous deletion of a previously unreported copy number variation in a patient with this phenotype could be interpreted as a rare recessive form. However, this case has to be viewed in the context of the <italic>FOXC1</italic> mutation and lack of other siblings in whom we can verify the segregation pattern of this deletion with respect to the classic aniridia phenotype. In other words, we caution against the over-interpretation of this finding as an example of a recessive form of aniridia at this time. It is hoped that our ongoing analysis of more classic aniridia cases in our highly consanguineous population will address this possibility. Future studies with even higher resolution microarrays are needed to further investigate the potential role of genomic copy number variation in classic aniridia patients without <italic>PAX6</italic> mutations.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study was funded in part by a KACST grant (08-MED497&#x2013;20) to F.S.A. The corresponding author had access to all data, confirms the integrity of all data, and confirms the accuracy of data analysis.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Spaeth</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Nowinski</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Margo</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Aniridia. A review.</article-title>
          <source>Surv Ophthalmol</source>
          <year>1984</year>
          <volume>28</volume>
          <fpage>621</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">6330922</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prosser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>PAX6 mutations reviewed.</article-title>
          <source>Hum Mutat</source>
          <year>1998</year>
          <volume>11</volume>
          <fpage>93</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">9482572</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hoovers</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>de Kraker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Crolla</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.</article-title>
          <source>J Med Genet</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>787</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">17630404</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O'Keefe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Aniridia: Current pathology and management.</article-title>
          <source>Acta Ophthalmol</source>
          <year>2008</year>
          <volume>86</volume>
          <fpage>708</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">18937825</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Axenfeld-Rieger syndrome in the age of molecular genetics.</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>107</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">11004268</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Searby</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Walton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Mackey</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Kawase</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kanis</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sheffield</surname>
              <given-names>VC</given-names>
            </name>
          </person-group>
          <article-title>A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye.</article-title>
          <source>Am J Hum Genet</source>
          <year>2001</year>
          <volume>68</volume>
          <fpage>364</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">11170889</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehmann</surname>
              <given-names>OJ</given-names>
            </name>
            <name>
              <surname>Ebenezer</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ocaka</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leroy</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Hitchings</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Povey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khaw</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma.</article-title>
          <source>Am J Hum Genet</source>
          <year>2000</year>
          <volume>67</volume>
          <fpage>1129</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">11007653</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Buckley</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Klintworth</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Thresher</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Axenfeld-Rieger syndrome. A spectrum of developmental disorders.</article-title>
          <source>Surv Ophthalmol</source>
          <year>1985</year>
          <volume>29</volume>
          <fpage>387</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="pmid">3892740</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Honkanen</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Swiderski</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sheffield</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>A family with axenfeld-rieger syndrome and peters anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene.</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>135</volume>
          <fpage>368</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">12614756</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Aldahmesh</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Al-Abdi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mohamed</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Hashem</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Al-Ghamdi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Molecular characterization of newborn glaucoma including a distinct aniridic phenotype.</article-title>
          <source>Ophthalmic Genet</source>
          <year>2011</year>
          <pub-id pub-id-type="pmid">21306220</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semina</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Mintz-Hittner</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Bitoun</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Reiter</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Funkhauser</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Daack-Hirsch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD.</article-title>
          <source>Nat Genet</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>167</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">9620774</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jamieson</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Perveen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Carette</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yardley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Donnai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Munier</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma.</article-title>
          <source>Hum Mol Genet</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>33</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">11772997</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Autozygome Decoded.</article-title>
          <source>Genet Med</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>765</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">21189493</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Aldahmesh</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>PAX6 analysis of two unrelated families from the Arabian Peninsula with classic hereditary aniridia.</article-title>
          <source>Ophthalmic Genet</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>145</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">18766996</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fetterman</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Mirzayans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a novel FOXC1 mutation, P297S, identified in two individuals with anterior segment dysgenesis.</article-title>
          <source>Clin Genet</source>
          <year>2009</year>
          <volume>76</volume>
          <fpage>296</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19793056</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Darr</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Science and society: Genetic counselling and customary consanguineous marriage.</article-title>
          <source>Nat Rev Genet</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>225</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11972160</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strungaru</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Dinu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>228</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">17197537</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The association between copy number variations in glutathione S-transferase M1 and T1 and age-related cataract in a Han Chinese population.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>3924</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">20335620</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid-Kubista</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Tosakulwong</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ryu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hecker</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Baratz</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>AO</given-names>
            </name>
          </person-group>
          <article-title>Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>5070</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19553609</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Aldahmesh</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Al-Amri</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Heterozygous FOXC1 mutation (M161K) associated with congenital glaucoma and aniridia in an infant and a milder phenotype in her mother.</article-title>
          <source>Ophthalmic Genet</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>67</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">18484311</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perveen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Clayton-Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Churchill</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van Heyningen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>McKeown</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Super</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Phenotypic variability and asymmetry of rieger syndrome associated with PITX2 mutations.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2456</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">10937553</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Footz</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Mirzayans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>3573</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19279310</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
